BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2146884)

  • 21. Guanine nucleotide regulation of [3H]vasopressin binding to liver plasma membranes and solubilized receptors. Evidence for the involvement of a guanine nucleotide regulatory protein.
    Bojanic D; Fain JN
    Biochem J; 1986 Dec; 240(2):361-5. PubMed ID: 2949738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.
    Stassen FL; Heckman G; Schmidt D; Aiyar N; Nambi P; Crooke ST
    Mol Pharmacol; 1987 Mar; 31(3):259-66. PubMed ID: 2951584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstitution of the rat liver vasopressin receptor coupled to guanine nucleotide-binding proteins.
    Dickey BF; Fishman JB; Fine RE; Navarro J
    J Biol Chem; 1987 Jun; 262(18):8738-42. PubMed ID: 2954955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubilization of a guanine nucleotide-sensitive form of vasopressin V2 receptors from porcine kidney.
    Aiyar N; Valinski W; Nambi P; Minnich M; Stassen FL; Crooke ST
    Arch Biochem Biophys; 1989 Feb; 268(2):698-706. PubMed ID: 2521556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of monovalent and divalent cations and of guanine nucleotides on binding of vasopressin to the rat mesenteric vasculature.
    Larivière R; Schiffrin EL
    Can J Physiol Pharmacol; 1987 Jun; 65(6):1171-81. PubMed ID: 2957041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of ANG II and AVP receptors in isolated hepatocytes of pregnant rats.
    Massicotte G; Coderre L; Chiasson JL; Thibault G; Schiffrin EL; St-Louis J
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E597-605. PubMed ID: 2333959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A V1-vascular vasopressin antagonist suitable for radioiodination and photoaffinity labeling.
    Thibonnier M; Chehade N; Hinko A
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):471-5. PubMed ID: 2369497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
    Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
    Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal tubular vasopressin receptors downregulated by dehydration.
    Steiner M; Phillips MI
    Am J Physiol; 1988 Mar; 254(3 Pt 1):C404-10. PubMed ID: 2831732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors.
    Kelly JM; Abrahams JM; Phillips PA; Mendelsohn FA; Grzonka Z; Johnston CI
    J Recept Res; 1989; 9(1):27-41. PubMed ID: 2521670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization and quantification of nonapeptide binding sites in the kidney of Xenopus laevis: evidence for the existence of two different nonapeptide receptors.
    Kloas W; Hanke W
    Gen Comp Endocrinol; 1992 Jan; 85(1):71-8. PubMed ID: 1563620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin receptors in rat brain and kidney: studies using a radio-iodinated V1 receptor antagonist.
    Phillips PA; Kelly JM; Abrahams JM; Grzonka Z; Paxinos G; Mendelsohn FA; Johnston CI
    J Hypertens Suppl; 1988 Dec; 6(4):S550-3. PubMed ID: 2977179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a 3H-arginine8-vasopressin binding site in the cingulate gyrus of the rat pup.
    Szot P; Myers KM; Swank M; Dorsa DM
    Peptides; 1989; 10(6):1231-7. PubMed ID: 2622802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells.
    Jamil KM; Watanabe T; Nakao A; Okuda T; Kurokawa K
    Biochem Biophys Res Commun; 1993 Jun; 193(2):738-43. PubMed ID: 8390252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic and nuclear signaling pathways of V1-vascular vasopressin receptors.
    Thibonnier M; Bayer AL; Leng Z
    Regul Pept; 1993 Apr; 45(1-2):79-84. PubMed ID: 8511370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubilization and purification of the Ni-stimulated arginine-vasopressin binding site of rat brain membranes.
    Junig JT; Abood LG
    Neurochem Res; 1987 Sep; 12(9):809-17. PubMed ID: 3670523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of vasopressin-activated human platelet high affinity GTPase.
    Vittet D; Cantau B; Mathieu MN; Chevillard C
    Biochem Biophys Res Commun; 1988 Jul; 154(1):213-8. PubMed ID: 2840065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of vasopressin receptor in rat lung.
    Tahara A; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Neuropeptides; 1998 Jun; 32(3):281-6. PubMed ID: 10189064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of arginine vasopressin receptors in the clonal murine Leydig-derived TM3 cell line.
    Maggi M; Morris PL; Kassis S; Rodbard D
    Int J Androl; 1989 Feb; 12(1):65-71. PubMed ID: 2714874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand.
    Trinder D; Stephenson JM; Gao X; Phillips PA; Risvanis J; Johnston CI
    Peptides; 1991; 12(6):1195-200. PubMed ID: 1815207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.